Joshua Hansen

15 Patents

• US125772232026

  Processes for Preparing 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

  Celgene Corporation

  0 cites
• US125105332025

  Methods for Treating Multiple Myeloma and the Use of Companion Biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile

  Celgene Corporation

  0 cites
• US124862812025

  Substituted 1-oxo-isoindoline-5-carboxamide Compounds, Compositions Thereof, and Methods of Treatment Therewith

  Celgene Corporation

  0 cites
• US124042412025

  Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione Compounds, Compositions Thereof, and Methods of Treatment Therewith

  Celgene Corporation

  0 cites
• US122274902025

  Cereblon Binding Compounds, Compositions Thereof, and Methods of Treatment Therewith

  Celgene Corporation

  0 cites
• US121876992025

  GSPT1 Compounds and Methods of Use of the Novel Compounds

  BRISTOL-MYERS SQUIBB COMPANY

  0 cites
• US121039202024

  Cereblon Binding Compounds, Compositions Thereof, and Methods of Treatment Therewith

  Celgene Corporation

  0 cites
• US120297382024

  Antiproliferative Compounds and Methods of Use Thereof

  Celgene Corporation

  0 cites
• US119458042024

  Substituted 4-aminoisoindoline-1,3-dione Compounds, Compositions Thereof, and Methods of Treatment Therewith

  Celgene Corporation

  0 cites
• US118732832024

  Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione Compounds, Compositions Thereof, and Methods of Treatment Therewith

  Celgene Corporation

  0 cites
• US117390752023

  Cereblon Binding Compounds, Compositions Thereof, and Methods of Treatment Therewith

  Celgene Corporation

  0 cites
• US117260802023

  Methods for Treating Multiple Myeloma and the Use of Companion Biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-l-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile

  Celgene Corporation

  0 cites
• US116344072023

  Cereblon Binding Compounds, Compositions Thereof, and Methods of Treatment Therewith

  Celgene Corporation

  0 cites
• US115901392023

  Substituted Aminopurine Compounds, Compositions Thereof, and Methods of Treatment Therewith

  Signal Pharmaceuticals, LLC

  0 cites
• US115603712023

  Cereblon Binding Compounds, Compositions Thereof, and Methods of Treatment Therewith

  Celgene Corporation

  0 cites